MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-23-0026758
Hariansh Pharmaceuticals Private Limited
Hariansh Pharmaceuticals Private Limited - food and beverages in Nashik, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.19 Cr
▲ 270% YoY
Net profit · FY 2024
₹18.56 Lakh
Net margin 8.5%
EBITDA · FY 2024
₹26.71 Lakh
EBITDA margin 12.2%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
7
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Hariansh Pharmaceuticals Private Limited
Data last updated:
Hariansh Pharmaceuticals Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 26 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC297851.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Yangya Dutta Jena and Pramod Kumar Jena.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A103 Dream Citi 06 Lemon Opp Fame Theatre Ringh Road Up Nagar, Nashik, Maharashtra, India – 422006.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.19 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹18.56 Lakh (net margin 8.5%) and EBITDA of ₹26.71 Lakh (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 274% over three years.
Hariansh Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0026758). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24304MH2017PTC297851
Registration Number 297851
Incorporation Date 26 July 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 01 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-23-0026758
Recognitions & Rankings of Hariansh Pharmaceuticals
Contact details
Hariansh Pharmaceuticals Private Limited's registered office is in Nashik, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA103 Dream Citi 06 Lemon Opp Fame Theatre Ringh Road Up Nagar, Nashik, Maharashtra, India – 422006
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Hariansh Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Hariansh Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Hariansh Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hariansh Pharmaceuticals Private Limited, buy the company report.
Financials of Hariansh Pharmaceuticals Private Limited
FY 2025 filings availableHariansh Pharmaceuticals Private Limited reported revenue of ₹2.19 Cr (up 270% YoY) for FY 2024.
Revenue · FY 2024
₹2.19 Cr ▲ 270%
Net profit · FY 2024
₹18.56 Lakh margin 8.5%
EBITDA · FY 2024
₹26.71 Lakh margin 12.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 270%
3 years · compounded
▲ 274%
EBITDA CAGR growth
5 years · compounded
▲ 116%
Revenue has grown at a compounded annual rate (CAGR) of 274% over three years, including 270% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.2% | ||||
| Net Profit Margin | 8.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hariansh Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hariansh Pharmaceuticals Private Limited
Hariansh Pharmaceuticals has 7 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yangya Dutta Jena | Director | 26 Jul 2017 | 9 Years 3 Months | Current |
| Pramod Kumar Jena | Director | 26 Jul 2017 | 9 Years 3 Months | Current |
| Bijayalaxmi Jena | Director | 22 May 2023 | 3 Years 5 Months | Current |
| Alakananda Mishra Also directs: Benecy Enterprises Private Limited | Director | 22 May 2023 | 3 Years 5 Months | Current |
| Manish Kumar Jena | Director | 26 Jul 2017 | 9 Years 3 Months | Current |
| Usha Rani Jena | Director | 26 Jul 2017 | 9 Years 3 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Hariansh Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esvy Life Sciences Private Limited | ₹2.21 Cr (FY 2025) | 20.0% | Begumpet, Hyderabad, Telangana, India | |||
| Ciel Pharma Private Limited | ₹2.2 Cr (FY 2022) | 20.0% | Lucknow, Uttar Pradesh, India | |||
| Hariansh Pharmaceuticals Private Limitedthis company | ₹2.19 Cr (FY 2024) | ₹18.56 Lakh | 8.5% | 270.0% | Nashik, Maharashtra, India | |
| Cellbless Healthcare Private Limited | ₹2.19 Cr (FY 2023) | 0.0% | Lucknow, Uttar Pradesh, India | |||
| Maccare Drugs Private Limited | ₹2.18 Cr (FY 2025) | 12.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Hariansh Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hariansh Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hariansh Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hariansh Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hariansh Pharmaceuticals Private Limited has 7 board changes on record since 2017: 7 appointments. The latest: Alakananda Mishra was appointed as Director on 22 May 2023.
AGM
Hariansh Pharmaceuticals Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records.
Filing
Hariansh Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Alakananda Mishra was appointed as Director.
Appointed
Bijayalaxmi Jena was appointed as Director.
Appointed
Manish Kumar Jena was appointed as Director.
Appointed
Poojarani Nayak was appointed as Director.
Appointed
Pramod Kumar Jena was appointed as Director.
Appointed
Usha Rani Jena was appointed as Director.
Appointed
Yangya Dutta Jena was appointed as Director.
Incorporation
26 Jul 2017
Hariansh Pharmaceuticals Private Limited was registered on 26 Jul 2017 with Roc Mumbai Ii & aged 9 years 3 months as per MCA records.
Frequently asked questions
Hariansh Pharmaceuticals is an active private limited company based in Nashik, Maharashtra, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 26 July 2017 (9+ years old) and is registered under CIN U24304MH2017PTC297851.
Hariansh Pharmaceuticals has 7 current directors:
- Yangya Dutta Jena - Director
- Pramod Kumar Jena - Director
- Bijayalaxmi Jena - Director
- Alakananda Mishra - Director
- Manish Kumar Jena - Director
- Usha Rani Jena - Director
- Poojarani Nayak - Director
The latest financial statements of Hariansh Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 01 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Hariansh Pharmaceuticals is U24304MH2017PTC297851. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hariansh Pharmaceuticals was incorporated on 26 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Hariansh Pharmaceuticals by revenue are Esvy Life Sciences Private Limited, Ciel Pharma Private Limited, Cellbless Healthcare Private Limited, Maccare Drugs Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Alakananda Mishra was appointed as Director on 22 May 2023. Bijayalaxmi Jena was appointed as Director on 22 May 2023. Manish Kumar Jena was appointed as Director on 26 Jul 2017. Hariansh Pharmaceuticals has 7 board changes on record in total.
Yes, Hariansh Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-23-0026758).
The registered office of Hariansh Pharmaceuticals is at A103 Dream Citi 06 Lemon Opp Fame Theatre Ringh Road Up Nagar, Nashik, Maharashtra, India – 422006.
Hariansh Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
The compliance status of Hariansh Pharmaceuticals is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages